首页> 美国卫生研究院文献>The British Journal of Ophthalmology >Management of varicella zoster virus retinitis in AIDS
【2h】

Management of varicella zoster virus retinitis in AIDS

机译:艾滋病中水痘带状疱疹病毒性视网膜炎的治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

AIMS/BACKGROUND—Varicella zoster virus retinitis (VZVR) in patients with AIDS, also called progressive outer retinal necrosis (PORN), is a necrotising viral retinitis which has resulted in blindness in most patients. The purposes of this study were to investigate the clinical course and visual outcome, and to determine if the choice of a systemic antiviral therapy affected the final visual outcome in patients with VZVR and AIDS.
METHODS—A review of the clinical records of 20 patients with VZVR from six centres was performed. Analysis of the clinical characteristics at presentation was performed. Kruskall-Wallis non-parametric one way analysis of variance (KWAOV) of the final visual acuities of patients treated with acyclovir, ganciclovir, foscarnet, or a combination of foscarnet and ganciclovir was carried out.
RESULTS—Median follow up was 6 months (range 1.3-26 months). On presentation, 14 of 20 patients (70%) had bilateral disease, and 75% (15 of 20 patients) had previous or concurrent extraocular manifestations of VZV infection. Median initial and final visual acuities were 20/40 and hand movements, respectively. Of 39 eyes involved, 19 eyes (49%) were no light perception at last follow up; 27 eyes (69%) developed rhegmatogenous retinal detachments. Patients treated with combination ganciclovir and foscarnet therapy or ganciclovir alone had significantly better final visual acuity than those treated with either acyclovir or foscarnet (KWAOV: p = 0.0051).
CONCLUSIONS—This study represents the second largest series, the longest follow up, and the first analysis of visual outcomes based on medical therapy for AIDS patients with VZVR. Aggressive medical treatment with appropriate systemic antivirals may improve long term visual outcome in patients with VZVR. Acyclovir appears to be relatively ineffective in treating this disease.

机译:目的/背景-艾滋病患者的水痘带状疱疹病毒性视网膜炎(VZVR),也称为进行性视网膜外坏死(PORN),是一种坏死性病毒性视网膜炎,已导致大多数患者失明。这项研究的目的是调查临床过程和视觉效果,并确定系统性抗病毒治疗的选择是否会影响VZVR和AIDS患者的最终视觉效果。
方法-回顾临床记录对来自六个中心的20例VZVR患者进行了研究。进行临床表现分析。对使用阿昔洛韦,更昔洛韦,膦甲酸或结合使用膦甲酸和更昔洛韦治疗的患者的最终视力进行Kruskall-Wallis非参数单向方差分析(KWAOV)。
结果—进行了中位随访6个月(范围1.3-26个月)。在介绍中,20例患者中有14例(70%)患有双侧疾病,75%的患者(20例中的15例)既往或同时存在VZV感染的眼外表现。初始和最终视力的中位数分别为20/40和手部运动。在涉及的39只眼睛中,有19只(sup> )眼睛(49%)在最后一次随访中没有光感; 27眼(69%)出现了流源性视网膜脱离。更昔洛韦联合膦甲酸治疗或单独使用更昔洛韦治疗的患者的最终视力明显优于无环鸟苷或膦甲酸治疗的患者(KWAOV:p = 0.0051)。
结论—该研究是第二大系列,随访时间最长以及基于药物治疗VZVR艾滋病患者的视觉结果的首次分析。用适当的全身抗病毒药进行积极的药物治疗可以改善VZVR患者的长期视觉效果。阿昔洛韦似乎在治疗这种疾病方面相对无效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号